Rovaldi Christopher
- SEC CIK
- 0001706040
No open-market purchases or sales filed in the past year.
Current role at each company
- KROS Keros Therapeutics, Inc.Chief Operating Officeras of Feb 19, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rovaldi Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2022 (view filing) | Apr 6 | 2 days | Rovaldi ChristopherChief Operating Officer | SSale | −1.73K | $65.00 | −$112.3K | −100.0%0 after | |
| Apr 5, 2022 (view filing) | Apr 1 | 4 days | Rovaldi ChristopherChief Operating Officer | SSale | −864 | $57.49 | −$49.7K | −100.0%0 after | 5 lots |